0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Procaine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6U8513
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Procaine Market Insights Forecast to 2028
BUY CHAPTERS

Global Procaine Market Research Report 2025

Code: QYRE-Auto-6U8513
Report
July 2025
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Procaine Market Size

The global market for Procaine was valued at US$ 1718 million in the year 2024 and is projected to reach a revised size of US$ 2406 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Procaine Market

Procaine Market

Procaine is a local anesthetic drug of the amino ester group. It is used primarily to reduce the pain of intramuscular injection of penicillin, and it is also used in dentistry. Owing to the ubiquity of the trade name Novocain, in some regions, procaine is referred to generically as novocaine. It acts mainly as a sodium channel blocker. Today it is used therapeutically in some countries due to its sympatholytic, anti-inflammatory, perfusion-enhancing, and mood-enhancing effects
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Procaine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procaine.
The Procaine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Procaine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Procaine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Procaine Market Report

Report Metric Details
Report Name Procaine Market
Accounted market size in year US$ 1718 million
Forecasted market size in 2031 US$ 2406 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Powder
Segment by Application
  • Hospital
  • Drug Store
  • On-line
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly and Company, Consolidated Pharmaceutical, Pfizer, Bristol-Myers Squibb, Bel Mar Laboratories, Elkins Sinn, Bayer, Watson Laboratories, RNP Pharmaceuticals, Tbilchempharma, SÜDmedica Gmbh, Grindeks, Towa Yakuhin, Hikari Seiyaku, Köhler-Pharma, Ardeapharma, Stada, Fuso Pharmaceutical, Hevert-Arzneimittel, Teofarma, Richter Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Procaine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Procaine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Procaine Market growing?

Ans: The Procaine Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Procaine Market size in 2031?

Ans: The Procaine Market size in 2031 will be US$ 2406 million.

Who are the main players in the Procaine Market report?

Ans: The main players in the Procaine Market are Eli Lilly and Company, Consolidated Pharmaceutical, Pfizer, Bristol-Myers Squibb, Bel Mar Laboratories, Elkins Sinn, Bayer, Watson Laboratories, RNP Pharmaceuticals, Tbilchempharma, SÜDmedica Gmbh, Grindeks, Towa Yakuhin, Hikari Seiyaku, Köhler-Pharma, Ardeapharma, Stada, Fuso Pharmaceutical, Hevert-Arzneimittel, Teofarma, Richter Pharma

What are the Application segmentation covered in the Procaine Market report?

Ans: The Applications covered in the Procaine Market report are Hospital, Drug Store, On-line

What are the Type segmentation covered in the Procaine Market report?

Ans: The Types covered in the Procaine Market report are Injection, Powder

Recommended Reports

Anesthetic Drugs

Pain Management

Sleep and Analgesics

1 Procaine Market Overview
1.1 Product Definition
1.2 Procaine by Type
1.2.1 Global Procaine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Powder
1.3 Procaine by Application
1.3.1 Global Procaine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 On-line
1.4 Global Procaine Market Size Estimates and Forecasts
1.4.1 Global Procaine Revenue 2020-2031
1.4.2 Global Procaine Sales 2020-2031
1.4.3 Global Procaine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Procaine Market Competition by Manufacturers
2.1 Global Procaine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Procaine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Procaine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Procaine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Procaine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Procaine, Product Type & Application
2.7 Global Key Manufacturers of Procaine, Date of Enter into This Industry
2.8 Global Procaine Market Competitive Situation and Trends
2.8.1 Global Procaine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Procaine Players Market Share by Revenue
2.8.3 Global Procaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Procaine Market Scenario by Region
3.1 Global Procaine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Procaine Sales by Region: 2020-2031
3.2.1 Global Procaine Sales by Region: 2020-2025
3.2.2 Global Procaine Sales by Region: 2026-2031
3.3 Global Procaine Revenue by Region: 2020-2031
3.3.1 Global Procaine Revenue by Region: 2020-2025
3.3.2 Global Procaine Revenue by Region: 2026-2031
3.4 North America Procaine Market Facts & Figures by Country
3.4.1 North America Procaine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Procaine Sales by Country (2020-2031)
3.4.3 North America Procaine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Procaine Market Facts & Figures by Country
3.5.1 Europe Procaine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Procaine Sales by Country (2020-2031)
3.5.3 Europe Procaine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Procaine Market Facts & Figures by Region
3.6.1 Asia Pacific Procaine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Procaine Sales by Region (2020-2031)
3.6.3 Asia Pacific Procaine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Procaine Market Facts & Figures by Country
3.7.1 Latin America Procaine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Procaine Sales by Country (2020-2031)
3.7.3 Latin America Procaine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Procaine Market Facts & Figures by Country
3.8.1 Middle East and Africa Procaine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Procaine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Procaine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Procaine Sales by Type (2020-2031)
4.1.1 Global Procaine Sales by Type (2020-2025)
4.1.2 Global Procaine Sales by Type (2026-2031)
4.1.3 Global Procaine Sales Market Share by Type (2020-2031)
4.2 Global Procaine Revenue by Type (2020-2031)
4.2.1 Global Procaine Revenue by Type (2020-2025)
4.2.2 Global Procaine Revenue by Type (2026-2031)
4.2.3 Global Procaine Revenue Market Share by Type (2020-2031)
4.3 Global Procaine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Procaine Sales by Application (2020-2031)
5.1.1 Global Procaine Sales by Application (2020-2025)
5.1.2 Global Procaine Sales by Application (2026-2031)
5.1.3 Global Procaine Sales Market Share by Application (2020-2031)
5.2 Global Procaine Revenue by Application (2020-2031)
5.2.1 Global Procaine Revenue by Application (2020-2025)
5.2.2 Global Procaine Revenue by Application (2026-2031)
5.2.3 Global Procaine Revenue Market Share by Application (2020-2031)
5.3 Global Procaine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Company Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Procaine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly and Company Procaine Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Consolidated Pharmaceutical
6.2.1 Consolidated Pharmaceutical Company Information
6.2.2 Consolidated Pharmaceutical Description and Business Overview
6.2.3 Consolidated Pharmaceutical Procaine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Consolidated Pharmaceutical Procaine Product Portfolio
6.2.5 Consolidated Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Procaine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Procaine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Company Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Procaine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bristol-Myers Squibb Procaine Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Bel Mar Laboratories
6.5.1 Bel Mar Laboratories Company Information
6.5.2 Bel Mar Laboratories Description and Business Overview
6.5.3 Bel Mar Laboratories Procaine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bel Mar Laboratories Procaine Product Portfolio
6.5.5 Bel Mar Laboratories Recent Developments/Updates
6.6 Elkins Sinn
6.6.1 Elkins Sinn Company Information
6.6.2 Elkins Sinn Description and Business Overview
6.6.3 Elkins Sinn Procaine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Elkins Sinn Procaine Product Portfolio
6.6.5 Elkins Sinn Recent Developments/Updates
6.7 Bayer
6.7.1 Bayer Company Information
6.7.2 Bayer Description and Business Overview
6.7.3 Bayer Procaine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer Procaine Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Watson Laboratories
6.8.1 Watson Laboratories Company Information
6.8.2 Watson Laboratories Description and Business Overview
6.8.3 Watson Laboratories Procaine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Watson Laboratories Procaine Product Portfolio
6.8.5 Watson Laboratories Recent Developments/Updates
6.9 RNP Pharmaceuticals
6.9.1 RNP Pharmaceuticals Company Information
6.9.2 RNP Pharmaceuticals Description and Business Overview
6.9.3 RNP Pharmaceuticals Procaine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 RNP Pharmaceuticals Procaine Product Portfolio
6.9.5 RNP Pharmaceuticals Recent Developments/Updates
6.10 Tbilchempharma
6.10.1 Tbilchempharma Company Information
6.10.2 Tbilchempharma Description and Business Overview
6.10.3 Tbilchempharma Procaine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tbilchempharma Procaine Product Portfolio
6.10.5 Tbilchempharma Recent Developments/Updates
6.11 SÜDmedica Gmbh
6.11.1 SÜDmedica Gmbh Company Information
6.11.2 SÜDmedica Gmbh Description and Business Overview
6.11.3 SÜDmedica Gmbh Procaine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SÜDmedica Gmbh Procaine Product Portfolio
6.11.5 SÜDmedica Gmbh Recent Developments/Updates
6.12 Grindeks
6.12.1 Grindeks Company Information
6.12.2 Grindeks Description and Business Overview
6.12.3 Grindeks Procaine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Grindeks Procaine Product Portfolio
6.12.5 Grindeks Recent Developments/Updates
6.13 Towa Yakuhin
6.13.1 Towa Yakuhin Company Information
6.13.2 Towa Yakuhin Description and Business Overview
6.13.3 Towa Yakuhin Procaine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Towa Yakuhin Procaine Product Portfolio
6.13.5 Towa Yakuhin Recent Developments/Updates
6.14 Hikari Seiyaku
6.14.1 Hikari Seiyaku Company Information
6.14.2 Hikari Seiyaku Description and Business Overview
6.14.3 Hikari Seiyaku Procaine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hikari Seiyaku Procaine Product Portfolio
6.14.5 Hikari Seiyaku Recent Developments/Updates
6.15 Köhler-Pharma
6.15.1 Köhler-Pharma Company Information
6.15.2 Köhler-Pharma Description and Business Overview
6.15.3 Köhler-Pharma Procaine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Köhler-Pharma Procaine Product Portfolio
6.15.5 Köhler-Pharma Recent Developments/Updates
6.16 Ardeapharma
6.16.1 Ardeapharma Company Information
6.16.2 Ardeapharma Description and Business Overview
6.16.3 Ardeapharma Procaine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Ardeapharma Procaine Product Portfolio
6.16.5 Ardeapharma Recent Developments/Updates
6.17 Stada
6.17.1 Stada Company Information
6.17.2 Stada Description and Business Overview
6.17.3 Stada Procaine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Stada Procaine Product Portfolio
6.17.5 Stada Recent Developments/Updates
6.18 Fuso Pharmaceutical
6.18.1 Fuso Pharmaceutical Company Information
6.18.2 Fuso Pharmaceutical Description and Business Overview
6.18.3 Fuso Pharmaceutical Procaine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Fuso Pharmaceutical Procaine Product Portfolio
6.18.5 Fuso Pharmaceutical Recent Developments/Updates
6.19 Hevert-Arzneimittel
6.19.1 Hevert-Arzneimittel Company Information
6.19.2 Hevert-Arzneimittel Description and Business Overview
6.19.3 Hevert-Arzneimittel Procaine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Hevert-Arzneimittel Procaine Product Portfolio
6.19.5 Hevert-Arzneimittel Recent Developments/Updates
6.20 Teofarma
6.20.1 Teofarma Company Information
6.20.2 Teofarma Description and Business Overview
6.20.3 Teofarma Procaine Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Teofarma Procaine Product Portfolio
6.20.5 Teofarma Recent Developments/Updates
6.21 Richter Pharma
6.21.1 Richter Pharma Company Information
6.21.2 Richter Pharma Description and Business Overview
6.21.3 Richter Pharma Procaine Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Richter Pharma Procaine Product Portfolio
6.21.5 Richter Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Procaine Industry Chain Analysis
7.2 Procaine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Procaine Production Mode & Process Analysis
7.4 Procaine Sales and Marketing
7.4.1 Procaine Sales Channels
7.4.2 Procaine Distributors
7.5 Procaine Customer Analysis
8 Procaine Market Dynamics
8.1 Procaine Industry Trends
8.2 Procaine Market Drivers
8.3 Procaine Market Challenges
8.4 Procaine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Procaine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Procaine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Procaine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Procaine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Procaine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Procaine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Procaine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Procaine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Procaine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Procaine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Procaine, Product Type & Application
 Table 12. Global Key Manufacturers of Procaine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Procaine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procaine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Procaine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Procaine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Procaine Sales Market Share by Region (2020-2025)
 Table 19. Global Procaine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Procaine Sales Market Share by Region (2026-2031)
 Table 21. Global Procaine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Procaine Revenue Market Share by Region (2020-2025)
 Table 23. Global Procaine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Procaine Revenue Market Share by Region (2026-2031)
 Table 25. North America Procaine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Procaine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Procaine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Procaine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Procaine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Procaine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Procaine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Procaine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Procaine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Procaine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Procaine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Procaine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Procaine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Procaine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Procaine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Procaine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Procaine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Procaine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Procaine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Procaine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Procaine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Procaine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Procaine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Procaine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Procaine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Procaine Sales (K Units) by Type (2020-2025)
 Table 51. Global Procaine Sales (K Units) by Type (2026-2031)
 Table 52. Global Procaine Sales Market Share by Type (2020-2025)
 Table 53. Global Procaine Sales Market Share by Type (2026-2031)
 Table 54. Global Procaine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Procaine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Procaine Revenue Market Share by Type (2020-2025)
 Table 57. Global Procaine Revenue Market Share by Type (2026-2031)
 Table 58. Global Procaine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Procaine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Procaine Sales (K Units) by Application (2020-2025)
 Table 61. Global Procaine Sales (K Units) by Application (2026-2031)
 Table 62. Global Procaine Sales Market Share by Application (2020-2025)
 Table 63. Global Procaine Sales Market Share by Application (2026-2031)
 Table 64. Global Procaine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Procaine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Procaine Revenue Market Share by Application (2020-2025)
 Table 67. Global Procaine Revenue Market Share by Application (2026-2031)
 Table 68. Global Procaine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Procaine Price (US$/Unit) by Application (2026-2031)
 Table 70. Eli Lilly and Company Company Information
 Table 71. Eli Lilly and Company Description and Business Overview
 Table 72. Eli Lilly and Company Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Eli Lilly and Company Procaine Product
 Table 74. Eli Lilly and Company Recent Developments/Updates
 Table 75. Consolidated Pharmaceutical Company Information
 Table 76. Consolidated Pharmaceutical Description and Business Overview
 Table 77. Consolidated Pharmaceutical Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Consolidated Pharmaceutical Procaine Product
 Table 79. Consolidated Pharmaceutical Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Procaine Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Bristol-Myers Squibb Company Information
 Table 86. Bristol-Myers Squibb Description and Business Overview
 Table 87. Bristol-Myers Squibb Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bristol-Myers Squibb Procaine Product
 Table 89. Bristol-Myers Squibb Recent Developments/Updates
 Table 90. Bel Mar Laboratories Company Information
 Table 91. Bel Mar Laboratories Description and Business Overview
 Table 92. Bel Mar Laboratories Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bel Mar Laboratories Procaine Product
 Table 94. Bel Mar Laboratories Recent Developments/Updates
 Table 95. Elkins Sinn Company Information
 Table 96. Elkins Sinn Description and Business Overview
 Table 97. Elkins Sinn Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Elkins Sinn Procaine Product
 Table 99. Elkins Sinn Recent Developments/Updates
 Table 100. Bayer Company Information
 Table 101. Bayer Description and Business Overview
 Table 102. Bayer Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bayer Procaine Product
 Table 104. Bayer Recent Developments/Updates
 Table 105. Watson Laboratories Company Information
 Table 106. Watson Laboratories Description and Business Overview
 Table 107. Watson Laboratories Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Watson Laboratories Procaine Product
 Table 109. Watson Laboratories Recent Developments/Updates
 Table 110. RNP Pharmaceuticals Company Information
 Table 111. RNP Pharmaceuticals Description and Business Overview
 Table 112. RNP Pharmaceuticals Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. RNP Pharmaceuticals Procaine Product
 Table 114. RNP Pharmaceuticals Recent Developments/Updates
 Table 115. Tbilchempharma Company Information
 Table 116. Tbilchempharma Description and Business Overview
 Table 117. Tbilchempharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Tbilchempharma Procaine Product
 Table 119. Tbilchempharma Recent Developments/Updates
 Table 120. SÜDmedica Gmbh Company Information
 Table 121. SÜDmedica Gmbh Description and Business Overview
 Table 122. SÜDmedica Gmbh Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. SÜDmedica Gmbh Procaine Product
 Table 124. SÜDmedica Gmbh Recent Developments/Updates
 Table 125. Grindeks Company Information
 Table 126. Grindeks Description and Business Overview
 Table 127. Grindeks Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Grindeks Procaine Product
 Table 129. Grindeks Recent Developments/Updates
 Table 130. Towa Yakuhin Company Information
 Table 131. Towa Yakuhin Description and Business Overview
 Table 132. Towa Yakuhin Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Towa Yakuhin Procaine Product
 Table 134. Towa Yakuhin Recent Developments/Updates
 Table 135. Hikari Seiyaku Company Information
 Table 136. Hikari Seiyaku Description and Business Overview
 Table 137. Hikari Seiyaku Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Hikari Seiyaku Procaine Product
 Table 139. Hikari Seiyaku Recent Developments/Updates
 Table 140. Köhler-Pharma Company Information
 Table 141. Köhler-Pharma Description and Business Overview
 Table 142. Köhler-Pharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Köhler-Pharma Procaine Product
 Table 144. Köhler-Pharma Recent Developments/Updates
 Table 145. Ardeapharma Company Information
 Table 146. Ardeapharma Description and Business Overview
 Table 147. Ardeapharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Ardeapharma Procaine Product
 Table 149. Ardeapharma Recent Developments/Updates
 Table 150. Stada Company Information
 Table 151. Stada Description and Business Overview
 Table 152. Stada Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Stada Procaine Product
 Table 154. Stada Recent Developments/Updates
 Table 155. Fuso Pharmaceutical Company Information
 Table 156. Fuso Pharmaceutical Description and Business Overview
 Table 157. Fuso Pharmaceutical Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Fuso Pharmaceutical Procaine Product
 Table 159. Fuso Pharmaceutical Recent Developments/Updates
 Table 160. Hevert-Arzneimittel Company Information
 Table 161. Hevert-Arzneimittel Description and Business Overview
 Table 162. Hevert-Arzneimittel Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Hevert-Arzneimittel Procaine Product
 Table 164. Hevert-Arzneimittel Recent Developments/Updates
 Table 165. Teofarma Company Information
 Table 166. Teofarma Description and Business Overview
 Table 167. Teofarma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Teofarma Procaine Product
 Table 169. Teofarma Recent Developments/Updates
 Table 170. Richter Pharma Company Information
 Table 171. Richter Pharma Description and Business Overview
 Table 172. Richter Pharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Richter Pharma Procaine Product
 Table 174. Richter Pharma Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Procaine Distributors List
 Table 178. Procaine Customers List
 Table 179. Procaine Market Trends
 Table 180. Procaine Market Drivers
 Table 181. Procaine Market Challenges
 Table 182. Procaine Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Procaine
 Figure 2. Global Procaine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Procaine Market Share by Type: 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Powder Product Picture
 Figure 6. Global Procaine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Procaine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug Store
 Figure 10. On-line
 Figure 11. Global Procaine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Procaine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Procaine Sales (2020-2031) & (K Units)
 Figure 14. Global Procaine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Procaine Report Years Considered
 Figure 16. Procaine Sales Share by Manufacturers in 2024
 Figure 17. Global Procaine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Procaine Players: Market Share by Revenue in Procaine in 2024
 Figure 19. Procaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Procaine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Procaine Sales Market Share by Country (2020-2031)
 Figure 22. North America Procaine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Procaine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Procaine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Procaine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Procaine Revenue Market Share by Region (2020-2031)
 Figure 34. China Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Procaine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Procaine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Procaine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Procaine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Procaine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Procaine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Procaine by Type (2020-2031)
 Figure 55. Global Procaine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Procaine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Procaine by Application (2020-2031)
 Figure 58. Global Procaine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Procaine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart